endocannabinoids
Figure 6: In-vitro responses of major endocannabinoids (2-AG, 1(3)-AG, 2-OG and 1(3)-OG) in rat brain homogenate treated with various inhibitors, 100 μM URB602 (MAGL inhibitor), 10 μM URB597 (FAAH inhibitor), and 10 μM MAFP (MAGL inhibitor). Data represent the mean of 3 independent experiments.